Optimize your long-term disease strategy with comprehensive market intelligence and takeaways.
Develop and validate your market forecasts and gauge the commercial outlook for new brands, generics and key markets with Clarivate (formerly Decision Resources Group) insights.
Review current treatments, profile emerging therapies and assess unmet needs and the corresponding opportunities to maximize your market share.
“Working with the Clarivate team showed me the power of linking claims with EHR for sizing and understanding patient populations and the impact on your business decisions – that was a lightbulb moment for me. I really value that partnership of being able to call up my Clarivate specialist to brainstorm how to use this integrated data to tackle our most challenging questions.”
Optimize your long-term disease strategy with comprehensive
market intelligence and takeaways
Understand the complete disease landscape and size global markets with real world data
Identify unmet needs to inform clinical development
Access commercial opportunities and optimize your strategy in China for nearly twenty key indications
Uncover the ‘why’ behind treatment pathways and brand usage
Increase brand share with visibility into treatment usage by line of therapy
Analyze treatment pathways to support brand positioning, strategic planning, and business development
Size the opportunity in this lucrative market and evaluate the disruptive effects of biosimilars
Optimize your market access strategy with brand-level insight
Assess the global pharma market without having to piece together information from a variety of sources